Celltrion Pharm

068760.KQ

42.76 USD

0.37

+0.87%

Overview

Last close

42.76 usd

Market cap

1.77B usd

52 week high

98.52 usd

52 week low

34.60 usd

Target price

93.2 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

9.2655

Price/Book Value

6.5273

Enterprise Value

1.83B usd

EV/Revenue

6.1116

EV/EBITDA

52.7012

Key financials

Revenue TTM

188.28M usd

Gross Profit TTM

49.98M usd

EBITDA TTM

29.33M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

639.79B usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.